Ebola Outbreak: Obama Thumbs Down Sending Experimental Serum to Africa
By Esther Tanquintic-Misa | August 7, 2014 1:53 PM EST
U.S. President Barack Obama has quashed calls of health experts to send to Africa the experimental ZMapp serum that was given to two Ebola-inflicted American health workers. The president thumbed down the proposal saying the drug still needs further testing if it indeed is working as it should.
U.S President Barack Obama hugs first lady Michelle as they watch the Diamond Head basketball game between Oregon State and Akron during their Christmas vacation in Honolulu, Hawaii, December 22, 2013.
"I think we've got to let the science guide us," Mr Obama said at a news conference to cap the first-ever U.S.-Africa Leaders Summit. "I don't think all the information is in on whether this drug is helpful."
Americans Dr Kent Brantly and Nancy Writebol contracted the deadly virus while doing missionary work in afflicted Liberia. They were given the experimental ZMapp drug before being repatriated to the U.S. The CDC claimed both are responding well to the treatment.
Mr Obama said the ZMapp drug still lacked enough information being that it's still on its testing stage when experts decided to use it on Brantly and Writebol.
Instead, the U.S. president wants to focus more on the Ebola-affected countries' public health systems.
"The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place," Mr Obama said.
"The countries were the first to admit they have been overwhelmed. They weren't able to identify and then isolate cases quickly enough. As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously."
Some Africans have blasted the seemingly cruel and greedy stance of Americans not to extend the experimental ZMapp drug to the very region that is badly needing it.
Not passing on the experimental ZMapp drug to African doctors "would be scandalous and criminal," LA Times quoted professor Alani Sulaimon Akanmu of the Lagos University Teaching Hospital.
Latest figures as of Monday released by the WHO showed 1,711 people in West Africa have been diagnosed with the disease, of which 932 have died - 363 in Guinea, 286 in Sierra Leone and 282 in Liberia.
San Diego-based Mapp Biopharmaceutical and Owensboro-based Kentucky BioProcessing (KBP), developer and manufacturer, respectively, of the experimental ZMapp drug, said it would take several months to produce it in volumes in case it gets the go signal from the authorities to ship it out to Africa.
To report problems or to leave feedback about this article, e-mail:
To contact the editor, e-mail:
Most Popular Slideshows
- 2014 MLB World Series Game 1: San Francisco Giants 7, Kansas City Royals 1 [PHOTOS]
- 2014 MLB World Series - Game 2: Kansas City Royals 7, San Francisco Giants 2 [PHOTOS]
- NFL Thursday Recap - Denver Broncos 35, San Diego Chargers 21: Peyton Manning Has 3 TDs In Easy Win [PHOTOS]
- 2014 MLB World Series Game 3: Kansas City Royals 3, San Francisco Giants 2 [PHOTOS]
Join the Conversation
- Australia's Low Birth Rate May Be Due to Low Confidence in Economy
- Fears Of Infection Spread Prompt Some US Hospitals To Refuse Ebola Patients
- Readers Slam a Book Showing That US Wealth And Power Rests on Slave Labour
- LG G Watch R To Be Available Globally Starting With Europe, North America And Asia Through Retail Sites And Play Store
- Young Teen Fighter Says ISIS Uses Drugs On Suicide Bombers To Get Them Perform The Act
- Xiaomi Redmi 1S vs. Sharp Aquos Crystal – Specifications, Features And Price Showdown
- Verizon Motorola Droid Turbo Leaked Live Images Surfaces, Scheduled To Get Unveiled On Oct 28
- Update HTC One M7 with LG G2 with Android 4.4.2 as Sprint OTA: Fixes and Installation
- U.S. Targets Buyers of ISIS Oil, Threatens Sanctions
- ISIS Syria Airstrike Bombing Has Killed 550 People, Civilians Included
- Russia Blocking OSCE Monitoring Of Its Border With Ukraine
- Russia Slams US 'Double Standards' In The Fight Against ISIS